How does a plasmid exist?

Plasmid DNA is a small double stranded circular DNA molecule that is exposed (without protein binding), structurally simple, independent of bacterial nucleoid DNA, and has the ability to self replicate. Image plasmids usually carry only a small number of genes, especially those related to antibiotic resistance; In addition, plasmids can be transmitted between different bacterial…

Read More
CRISPR-CAS system

CRISPRme, an off target prediction tool that can consider the impact of genetic variation

In recent years, CRISPR gene editing technology has attracted great attention due to its enormous potential in the treatment of hereditary diseases. However, the potential off target effects that may occur during gene editing have always been an important safety concern. In addition, different populations have different genetic information, which poses great difficulties in accurately…

Read More

Frontier | FDA approved new gene editing therapies for the treatment of OTC deficiency in clinical practice; LSTA1, a new drug for the treatment of osteosarcoma, has been recognized as an orphan drug

01 FDA approved new gene editing therapy for the treatment of OTC deficiency in clinical practice On April 4, 2024, the FDA approved the clinical study approval application for ECUR-506 for the treatment of neonatal patients with ornithine aminotransferase (OTC) deficiency. OTC deficiency, also known as hyperammonemia type II, is an X-linked genetic disease caused…

Read More
Characterization and synthetic biology strategies of GMPS

Using engineering bacteria to titrate hydrogen sulfide and induce concentration dependent effects on the host in the gut microbiota

Abstract Hydrogen sulfide (H2S) is a gaseous microbial metabolite, and its role in intestinal diseases is highly controversial. This is mainly due to the difficulty of accurately measuring H2S and the use of model systems that cannot accurately represent the human intestinal environment for research. In this paper, the engineered Escherichia coli designed by the…

Read More
Tetrahydropyrimidine biosynthesis pathway

The titer reaches 115.87 g/L, and under low salt conditions, the engineered glutamic acid rod bacterium produces tetrahydropyrimidine, which is the highest level among this strain to date

Many microorganisms accumulate compatible solutes to counteract external pressures such as high osmotic pressure, high temperature, drying, and freezing. Among numerous compatible solutes, tetrahydropyrimidine stands out for its significant efficacy in effectively protecting halophilic cells from osmotic pressure imbalance and maintaining the stability of intracellular biomolecules. Recent studies have shown that tetrahydropyrimidine has the potential…

Read More
Escherichia coli metabolic engineering technology

Analysis of metabolic engineering pathways and optimization in Escherichia coli

Metabolic engineering refers to the purposeful modification and modification of cellular metabolic pathways using genetic engineering techniques, altering cellular characteristics, and producing specific target products. Metabolic engineering has a history of 30 years since its development. From traditional modification techniques such as knocking out byproduct generation pathways, releasing product synthesis inhibition, and overexpressing key enzymes…

Read More

PNAS: A Simple and Robust Experimental Process for Protein Engineering

According to a new study by researchers at the University of Michigan, a protein engineering method using simple, cost-effective experiments and machine learning models can predict which proteins are effective for specific purposes. This method has profound potential in assembling proteins and peptides, and can be used for applications ranging from industrial tools to therapeutic…

Read More